reports
BMS Birlesik Metal Sanayi ve Ticaret Anonim Sirketi: 2 directors
Two Directors at BMS Birlesik Metal Sanayi ve Ticaret Anonim Sirketi sold 600,000 shares at between 34.070TRY and 34.110TRY. The significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by ...
Fitness Prime: 1 director
A director at Fitness Prime bought 300,000 shares at 0.000EGP and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
Hornbach Holding AG & Co KGaA: 1 director
A director at Hornbach Holding AG & Co KGaA bought 300 shares at 78.399EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...
- ABGSC Oil & Oil Services Research
- Haakon Amundsen
- Stian Wibstad
Presto Automation Announces Fiscal Third Quarter 2024 Financial Result...
Presto Automation Announces Fiscal Third Quarter 2024 Financial Results Successful Pilots of Presto Voice™ with Pure AI and Spanish Language Capabilities Focuses on Voice AI Solution for Drive-Thrus By Exiting Touch Pay-at-Table Solution SAN CARLOS, Calif., May 21, 2024 (GLOBE NEWSWIRE) -- -- (NASDAQ: ), one of the largest drive-thru AI and automation technology providers to the restaurant industry, today announced financial results for the 2024 fiscal third quarter ended March 31, 2024. “We are encouraged by the significant progress we are making in our Voice AI solution across many ...
Litchfield Hills Research reiterates buy recommendation at $10.00 per ...
Litchfield Hills Research reiterates buy recommendation at $10.00 per share New York and Bilbao, Spain, 21 May - US equity research firm Litchfield Hills Research has just published a new analysis of Virtualware (ENXTPA: MLVIR), reiterating its Buy recommendation at $10.00 per share. The report, signed by analyst Theodore R. O'Neill, reaffirms his ‘Buy’ recommendation and highlights the execution of the company's plan to achieve higher recurring revenue through SaaS subscriptions with the VIROO platform, along with its expansion in the US.He notes that ‘VIROO is becoming a g...
- ABGSC Strategy Research
- Bengt Jonassen
EQS-News: Kontron AG: Major order for smart wallboxes
EQS-News: Kontron AG / Key word(s): Development of Sales Kontron AG: Major order for smart wallboxes 21.05.2024 / 07:00 CET/CEST The issuer is solely responsible for the content of this announcement. Linz, 21.05.2024: Kontron AG, a global leader in IoT technology, has been greenlit to supply smart charging stations for electric vehicles for one of the world’s largest car manufacturers. Series production will begin in July 2024. The first stage of the contract is worth at least EUR 200 million. For the development of the fully networked charging solution, the IoT speciali...
EQS-News: Kontron AG: Großauftrag für intelligente Wallboxen
EQS-News: Kontron AG / Schlagwort(e): Umsatzentwicklung Kontron AG: Großauftrag für intelligente Wallboxen 21.05.2024 / 07:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Linz, 21.05.2024: Kontron AG, ein weltweit führender Anbieter von IoT-Technologie, hat die Freigabe zur Lieferung von intelligenten Ladestationen für Elektroautos von einem der weltweit größten Automobilhersteller erhalten. Die Serienproduktion wird im Juli 2024 beginnen. Das Auftragsvolumen beträgt im ersten Schritt zumindest 200 Millionen Euro. Bei der Entwickl...
- ABGSC Financials Research
- Jan Erik Gjerland
- Magnus Andersson
- Patrik Brattelius
Innate Pharma: Clarification concernant le statut de SAR443579
MARSEILLE, France--(BUSINESS WIRE)-- Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société ») a annoncé aujourd’hui qu’un abstract publié le 14 mai 2024 en amont du congrès de l’Association Européenne d’Hématologie 2024 (European Hematology Association – EHA), soumis par Sanofi, mentionne que SAR443579/IPH6101 aurait reçu le statut de « Breakthrough Designation ». Cette information est erronée. Comme communiqué précédemment, la molécule a reçu le statut « Fast Track » de la Food and Drug Administration (FDA), l’agence américaine des médicaments ...
DNO to Hold Fixed Income Investor Meetings
DNO to Hold Fixed Income Investor Meetings Oslo, 21 May 2024 – DNO ASA, the Norwegian oil and gas operator, today announced it has engaged DNB Markets, part of DNB Bank ASA, and Pareto Securities AS as Global Coordinators and Joint Bookrunners and with Arctic Securities AS as Joint Bookrunner to arrange fixed income investor meetings. Subject to inter alia market conditions and acceptable terms, a new senior unsecured bond issue with a tenor of five years may follow. The contemplated bond will materially have the same terms as DNO04, issued in September 2021. The purpose of the new...
Innate Pharma: Clarification Regarding SAR443579 Designation
MARSEILLE, France--(BUSINESS WIRE)-- Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that in an abstract published on 14 May 2024 for the European Hematology Association 2024 Congress on SAR443579/IPH6101, submitted by Sanofi, it was mentioned that the molecule received breakthrough designation. This is an error. The molecule has US FDA Fast Track Designation, as communicated before in June 2023. About ANKET® (Antibody-based NK cell Engager Therapeutics) is Innate's proprietary platform for developing next-generation, mul...
Planisware - Q1 2024 revenue - Strong start of the year and dynamic co...
Planisware - Q1 2024 revenue - Strong start of the year and dynamic commercial momentum Q1 2024 revenue Strong start of the year anddynamic commercial momentum Total revenue growth of +19.6% in constant currencies, reaching € 40.9 millionSolid commercial traction with existing clients and new logosFurther product enhancements and third-party industry analysts’ recognition2024 objectives confirmed Paris, France, May 21, 2024 – Planisware, a leading B2B provider of SaaS in the rapidly growing Project Economy market, announces today its revenue for Q1 2024. Total revenue amounted to € 40.9 ...
Planisware - Chiffre d'affaires T1 2024 - Bon début d'année et forte d...
Planisware - Chiffre d'affaires T1 2024 - Bon début d'année et forte dynamique commerciale Chiffres d’affaires du T1 2024 Bon début d'année et forte dynamique commerciale Chiffre d'affaires total : 40,9 millions d'euros ; en croissance de +19,6% à taux de change constantsForte dynamique commerciale avec de nouveaux clients et les clients existantsNouvelles améliorations produits et nouvelle confirmation du leadership de Planisware par les analystes industrielsObjectifs 2024 confirmés Paris, France, 21 mai 2024 – Planisware, un leader de l’édition de logiciels SaaS B2B dans le secteur en ...
Elliptic Labs Shipping AI Virtual Smart Sensor on vivo’s Y200 Smartpho...
OSLO, Norway--(BUSINESS WIRE)-- (OSE: ), a global AI software company and the world leader in AI Virtual Smart Sensors™ currently deployed in over 500 million devices, is announcing the deployment of its AI Virtual Proximity Sensor™ INNER BEAUTY® on vivo’s latest smartphone, the entry-level vivo Y200. The vivo Y200 will be available for the Chinese market and is powered by Elliptic Labs’ ’s . . “Elliptic Labs is excited to announce the launch of our AI Virtual Smart Sensor Platform™ in vivo's Y200, making it the 9th smartphone from vivo to use our technology,” said Laila Danielsen, CEO of E...
Valneva Appoints Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific O...
Valneva Appoints Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific Officer Saint-Herblain (France), May 21, 2024 – (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the appointment of Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific Officer (CSO) and Executive Committee member, effective June 3, 2024. Valneva decided to complement its Executive Team with an accomplished R&D leader to oversee the further evolution of the Company´s R&D portfolio. Specifically, Dr. Schuitemaker will focus on accelerating Valneva’s pre-clinical and translational R&D activi...
- Felix Fischer
Lucror Analytics - Morning Views Europe
Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar. To request full and unrestricted access to Lucror’s research and analytics platform, please visit
Mei Pharma Inc: 1 director
A director at Mei Pharma Inc maiden bought 7,900 shares at 3.162USD and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
Arab Developers Holding: 1 director
A director at Arab Developers Holding bought 14,665,966 shares at 0.000EGP and the significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.